Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 16 of 16

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Studies about the cooperative signaling between p75 NTR and Trk receptors in the modulation of choroidal neovascularization.

Paula Virginia Subirada Caldarone; Albana Tovo; María Victoria Vaglienti; Danisa Vicentin; Nicolás Ribotta; José Domingo Luna Pinto; Horacio Uri Saragovi; Maria Cecilia Sanchez; Agustin Anastasía; Pablo Federico Barcelona

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3030 – F0401.

ARVO Annual Meeting Abstract June 2021

The neurotrophin receptor p75 NTR as a new player in the development of choroidal neovascularization

Paula Virginia Subirada Caldarone; Maria Victoria Vaglienti; Maria Paula O`brien; Alejandra Jurado; Jose D Luna Pinto; Horacio Uri Saragovi; Maria Cecilia Sanchez; Agustín Anastasía; Pablo Federico Barcelona

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):643.

ARVO Annual Meeting Abstract June 2020

NEUROPROTECTIVE EFFECT OF MELATONIN LOADED IN ETHYLCELLULOSE NANOPARTICLES APPLIED TOPICALLY IN A RETINAL DEGENERATION MODEL IN RABBITS

Jose D Luna Pinto; Carolina del Valle Bessone; Sofía Mickaela Martinez; Marilyn Ann Marquez; Daniel Allemandi; Ágata Carpentieri; Daniela Quinteros

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2897.

ARVO Annual Meeting Abstract July 2019

VALIDATION OF LASER-INDUCED CHOROIDAL NEOVASCULARIZATION (CNV) MOUSE MODEL: PARTICIPATION OF α 2 M/LRP1 SYSTEM

Pablo Federico Barcelona; Paula Subirada; Tomas Nabil Saddi; Marilyn Ann Marquez; Maria Victoria Vaglienti; Magali Evelin Ridano; Gabriel Marquez; Maria Constanza Paz; Jose D Luna Pinto; Maria Cecilia Sanchez

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1257.

ARVO Annual Meeting Abstract July 2019

Comparison of eplerenone versus melatonin as therapeutic options for the treatment of non-resolving and chronic central serous chorioretinopathy

Tomas Nabil Saddi; Juan Pablo Real; Eleonora Lavaque; Ana Laura Gramajo; Claudio Patricio Juarez; Ruth Estela Rosenstein; Jose D Luna Pinto

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4078.

ARVO Annual Meeting Abstract July 2018

Comparative study of VEGF inhibitors in Oxygen Induced Retinopathy (OIR) mouse model: Vascular, non-vascular and functional implications

Magali Evelin Evelin Ridano; Maria Constanza Paz; Paula Virginia Subirada; Jose D Luna Pinto; Diego Omar Croci Russo; Pablo Federico Barcelona; Maria Victoria Vaglienti; Gabriel Adrian Rabinovich; Maria Cecilia Sanchez

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6072.

ARVO Annual Meeting Abstract June 2017

COMPARISON OF EPLERENONE VERSUS MELATONIN AS THERAPEUTIC OPTIONS FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

Eleonora Beatriz Lavaque; Laura Gramajo; Juan Pablo Real; Claudio P Juarez; Ruth Estela Rosenstein; Jose D Luna Pinto

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5932.

ARVO Annual Meeting Abstract June 2017

Use of discrete event simulation (DEM) to evaluate the clinical practices in neovascular age-related macular degeneration

Patricio Gerardo Schlottmann; Jose D Luna Pinto; Santiago Palma; Juan Pablo Real

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):428.

ARVO Annual Meeting Abstract June 2017

Galectin-1 involvement in neovascular retinopathies

Magali Evelin Evelin Ridano; Paula Virginia Subirada Caldarone; Maria Constanza Paz; Valeria E Lorenc; Juan Carlos Stupirski; Laura Gramajo; Jose D Luna Pinto; Diego Omar Croci; Gabriel Adrian Rabinovich; Maria Cecilia Sanchez

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3596.

ARVO Annual Meeting Abstract June 2017

THE rs4712527 POLYMORPHISM IN THE CDKAL1 GENE, AS A PROTECTIVE PREDICTOR OF PROLIFERATIVE DIABETIC RETINOPATHY DEVELOPMENT IN TYPE 2 DIABETIC PATIENTS.

Jose D Luna Pinto; Pablo Yang; Aylen Sein; Laura Gramajo; Emilia Aucar; Gabriel Marquez; Claudio P Juarez; Dante M Beltramo; Nestor W Soria

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1848.

ARVO Annual Meeting Abstract September 2016

Non-vascular alterations and functional impairment persist after Anti-VEGF therapy in Oxygen Induced Retinopathy (OIR) mouse model

Magali Evelin Ridano; Valeria Erika Lorenc; Paula Subirada; Maria Constanza Paz; Diego Omar Croci Russo; Jose D Luna Pinto; Gabriel Adrián Rabinovich; Maria Cecilia Sanchez

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3636.

ARVO Annual Meeting Abstract June 2015

Development of triamcionolone acetonide based lipid nanocapsules as platforms for ocular drug delivery

María Lina Formica; Gabriela Veronica Ullio Gamboa; Jean Pierre Benoit; Daniel Alberto Allemandi; Jose D Luna Pinto; Santiago Daniel Palma

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4152.

ARVO Annual Meeting Abstract April 2014

IGF-1 regulates MMP2 activity in a hypoxia-independent manner in Müller Cells

Valeria Lorenc; Jose D Luna Pinto; Gustavo Chiabrando; Maria Cecilia Sanchez

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1347.

ARVO Annual Meeting Abstract April 2014

Correlation between changes in visual acuity and time in age-related macular degeneration

Juan Pablo Real; Santiago Palma; Gladys Granero; Claudio P Juarez; Jose D Luna Pinto

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):602.

ARVO Annual Meeting Abstract April 2014

POTENTIAL THERAPEUTIC BENEFIT OF MELATONIN IN REFRACTORY CENTRAL SEROUS CHORIORETINOPATHY

Jose D Luna Pinto; Ana L Gramajo; Gabriel Marquez; Victor Torres; Claudio P Juarez; Ruth Estela Rosenstein

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6374.

ARVO Annual Meeting Abstract April 2011

Ocular Biocompatibility Of SC230 Celcuat Gel: Functional And Morphological Results

Jose D. Luna Pinto; Luciana G. Garcia; Ana L. Gramajo; Valeria Alacino; Juan P. Pusterla; Claudio P. Juarez; Hugo M. Fajreldines; Dante M. Beltramo

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5678.

Advertisement